Immunothérapie : une révolution dans la prise en charge du cancer de la vessie ? [Immunotherapy : a revolution in the management of urothelial bladder cancer ?]

Details

Ressource 1Download: RMS_585_2074.pdf (3620.08 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_2CC8F9CAC7B2
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Immunothérapie : une révolution dans la prise en charge du cancer de la vessie ? [Immunotherapy : a revolution in the management of urothelial bladder cancer ?]
Journal
Revue medicale suisse
Author(s)
Adam S.M., Derré L., Jichlinski P., Lucca I.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
29/11/2017
Peer-reviewed
Oui
Volume
13
Number
585
Pages
2074-2078
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
The treatment of urothelial bladder cancer has changed very little in recent years, with high rates of disease recurrence and progression, even in low aggressive urothelial bladder cancer. Immunotherapy has already proven its effectiveness as a treatment for several types of cancer and has been used in high-grade non-muscle-invasive bladder cancer for decades. Recent findings on immune checkpoints inhibitors have opened up a new chapter for treatment of bladder cancer, offering interesting therapeutic perspectives that could revolutionize the management.
Keywords
Disease Progression, Humans, Immunologic Factors, Immunotherapy, Neoplasm Recurrence, Local, Urinary Bladder Neoplasms/therapy, Urologic Neoplasms/therapy
Pubmed
Create date
06/12/2017 11:38
Last modification date
20/08/2019 13:11
Usage data